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Resumen
Este trabajo describe un método basado en la filosofía del enfriamiento simulado, para el
caso del estudio de la estabilidad de la red de interacción de proteínas en tejidos tumorales
y normales, a partir de datos de expresión de genes.
Presentamos una propuesta original para estudiar la inestabilidad que se da en las redes
de interacción de proteínas, basándonos en la conocida estrategia del Enfriamiento Simulado
como técnica de optimización adaptado para nuestro propósito.
La estrategia propuesta se ha verificado con datos de expresión de genes para diferentes
tejidos en estado normal y tumoral, sobre una red de interacción de proteínas. Con ella se
ha demostrado la hipótesis y motivación inicial con la que partimos: la expresión de genes
en tejidos tumorales desestabiliza más la red de interacción de proteínas frente a la expresión
génica en tejidos normales.
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Abstract
The aim of this project is to study the stability on the protein interaction network from
gene expression data on tumor and normal tissue, implementing for that several algorithms
based on the physical idea of Simulated Annealing.
We present a novel approach to identify the degree of destabilization based on the evo-
lution of the well-known Simulated Annealing as an optimization approach customized for
such purpose.
The proposed strategy is verified with gene expression data from different tissue in
normal and tumor cases, as well as a protein interaction network. With this approach
we demonstrate our hypothesis and initial motivation: gene expression in tumoral tissue
destabilizes more the protein interaction network comparing to the result normal tissue do.
Keywords
Simulated Annealing, Systems Biology, Artificial Intelligence, Gene Expression
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Chapter 1
Introduction
The availability of high-throughput experimental data has allowed construction of increas-
ingly comprehensive and accurate protein-protein interaction networks (interactome) and its
study is more frequently providing valuable information on biological systems. The structure
or topology of such networks sheds light on the complex cellular mechanisms and processes
as well as gives insight into evolutionary aspects of the proteins.
1.1 Motivation
Johnsson and Bates (2006) show that known cancer genes exhibit a network topology that
is different from that of protein not documented as being mutated in cancer. In particular,
cancer proteins show an increase in the number of proteins they interact with. They also
appear to participate in central hubs rather than peripheral ones, mirroring their greater
centrality and participation in networks that form the backbone of the proteome. In the
same way, Wachi et al. (2005) emphasize the high centrality of genes differentially expressed
in lung cancer.
Systems biology studies shed light on the relationships between genes, the complex cel-
lular mechanisms and processes as well as evolutionary aspects of the proteins. We can
combine different type of biological data in order to simulate several biological behaviours.
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The structure of the protein-protein interaction network varies depending on which pro-
tein is activated or expressed and also depending on the interaction protein partners. Mi-
croarray gene expression studies provide us the probabilities of proteins of being expressed
in certain conditions. For the entire protein interaction network we could simulate how the
topology changes in different conditions, from gene expression data.
1.2 Principle Objectives
The main idea is to simulate the dynamic structure of the protein interaction network in
tumor and normal tissues using gene expression data from the biological point of view.
The structure and topology of the protein network emphasize the different interactions
that proteins have. In turn, gene expression data provides somehow the probability of
proteins of being expressed. Combining these biological data, our intention is to simulate
the protein interaction network according to the probability of proteins to being expressed
(gene expression data) and compare these simulations in normal and tumoral studies.
The simulation consists in re-create different protein interaction networks according to
gene level expression data for different conditions; applying an approach based on the phi-
losophy of the simulated annealing principle, which has been applied to computational
problems (Duda et al. 2001), where optimization is a key issue.
In this work we map protein interactions in a network of nodes, where each node is
characterized by its state and its relations among the other nodes, allowing the application
of the simulated annealing process. With such purpose we define a new approach inspired
on the Deterministic Simulated Annealing algorithm proposed in Duda et al. (2001). This
explains the name given to our method, i.e. Pseudo-Deterministic Simulated Annealing.
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1.3 Organization of this work
This work is organized as follows: In the chapter 2 we introduce basic concepts in molecular
biology in order to better understand the biological problem presented in our study. The
biological data used in this study goes on the chapter 3 as well as the preprocessing and
normalization methods used on them. In the chapter 4 we present the new approach that
identifies the degree of destabilization based on the evolution of the well-known Simulated
Annealing (SA) approach followed by the results in chapter 5. The last chapter includes
either conclusions or future ideas.
3
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Chapter 2
Biological Concepts
2.1 Introduction to Molecular Biology
Cells are fundamental building blocks of living organisms. Cells contain a nucleus, mito-
chondria and chloroplasts, endoplasmatic reticulum, ribosomes, vacuoles, etc. The nucleus
is important organelle because it houses chromosomes which include the DNA. The DNA
is in essence a blueprint of the organism as it encodes information needed to synthesize
proteins.
DNA is an extremely long molecule that forms a double-helix. The double-helix backbone
of the molecule consists of sugars and phosphates, and there is one base attached to each
sugar. There are four types of bases: cytosine (C), guanine (G), adenine (A) and thymine
(T). The DNA consists of two strands, and each base attached to one strand forms a bond
with a corresponding base on the other strand.
Protein is a sequence of amino acids, and the functional subunit of DNA that encodes
a protein is called a gene. Protein is a class of macromolecules that carries out most of
the activities in the cell. Cells are largely made up of proteins: structural proteins that
give the cell rigidity and mobility, proteins that form pores in the cell membrane to control
the traffic of small molecules into and out of the cell, and receptor proteins that regulate
cellular activities in response to molecular signals from the growth medium or from other
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cells. Proteins are also responsible for most of the metabolic activities of cells. They
are essential for the synthesis and breakdown of organic molecules and for generating the
chemical energy needed for cellular activities.
In molecular and cell biology, the central dogma is the passage of information from DNA
to RNA to protein. Fig.2.1 displays a scheme of the central dogma: DNA sequence coding
for the first seven amino acids in a polypeptide chain. The DNA sequence specifies the
amino acid sequence through a molecule of RNA that serves as an intermediary “messen-
ger”. Although the decoding process is indirect, the net result is that each amino acid in
the polypeptide chain is specified by a group of three adjacent bases (codon) in the DNA
(translation). The term dogma means “set of beliefs”; it dates from the time the idea was
put forward first as theory. Since then the “dogma” has been confirmed experimentally, but
the term persists and it is not as simple as it seems. The central dogma is shown in Fig.2.1.
Figure 2.1: Central Dogma in Molecular Biology
The central dogma is the fundamental principle of molecular genetics because it summa-
rizes how the genetic information in DNA becomes expressed in the amino acid sequence in
a polypeptide chain.
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The transcription is the process of making a RNA copy from a sequence of DNA
(a gene). Transcription is the first step leading to gene expression. The stretch of DNA
transcribed into and RNA molecule (transcription unit) encodes at least one gene. If the
gene transcribed encodes a protein, the result of transcription is a messenger RNA (mRNA),
which will then be used to create that protein via the process of translation. Alternatively,
the transcribed gene may encode for either non-coding RNA genes (such as microRNA) or
ribosomal RNA (rRNA) or transfer RNA (tRNA), other components of the protein-assembly
process.
Gene expression is a two-step process in which DNA is converted into a protein it encodes.
The first step is DNA transcription. In this step, the information from the archival copy
of DNA is imprinted into short-lived mRNA. The structure of RNA is a little different,
it contains ribose instead of deoxyrybose, and the four bases that bind to it are cytosine
(C), guanine (G), adenine (A) and uracil (U). During transcription, DNA unfolds, and
mRNA is created by pairing mRNA bases with the bases of RNA. In this process C in DNA
translates to G, G to C, A to U, and T to A. After mRNA is translated, it is transported
to the ribosome. The second step, protein translation occurs at the ribosome. During
translation, the sequence of codons (triplets of bases) of mRNA is, with the help of tRNA,
translated into a sequence of aminoacids.
The control of gene expression causes most phenotypic differences in organisms. Since
many diseases result from complex changes on the molecular level, we need to observe and
model these processes on the system level. Gene regulatory circuits are an example of
machinery that allows us to depict gene expression graphically.
A measurement of the amount of gene product is sometimes used to infer how active
a gene is. Abnormal amount of gene product can be correlated with a deregulation of
the transcription that can directly cause anomalous behaviours related with a disease. An
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example of this can be seen in the study published by Nagel et al. (2012): a low expression
levels of ZHX2 is associated with a poor prognosis, indicating tumor suppresor activity in
B-cell malignancies. Płuciennika et al. (2006) also show that reduced WWOX expression
commonly observed in various neoplasias in cases of breast cancer is associated with markers
of bad prognosis; high level expression of WWOX is associated with better disease free
survival.
2.2 Gene Expression Analysis
Recent advances in biology provide different and diverse techniques and tools in order to
measure gene expression. The data used in this study comes from experimental studies done
with microarray technology, Affymetrix Human Genome U133 Plus2.0 Array [1].
A DNA microarray is a collection of microscopic DNA spots attached to a solid surface.
Scientist use DNA microarrays to measure the expression levels of a large numbers of genes
simultaneously or to genotype multiple regions of a genome.
The basic concept of microarray analysis is simple (Fig.2.2). RNA is harvested from a
cell type or tissue of interest and labeled to generate the target. This is hybridized to the
probe DNA sequences corresponding to specific genes that have been affixed, in a known
configuration, onto a solid matrix. Hybridization, based on Watson and Crick base pairing,
between probe and target provides a quantitative measure of the abundance of a particular
sequence in the target population. This information is captured digitally and subjected to
various analyses to extract biological information. Comparisons of hybridization patterns
enables the identification of mRNAs that differ in abundance in two or more target samples.
Thus microarrays provide a powerful tool with which to screen biological specimens for
alterations in the expression of mRNAs that accompany, and may regulate physiological
and pathological change.
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Figure 2.2: Steps in a Microarray Experiment
Microarray techniques are finding utility in gene discovery – the global description
of genes potentially involved in developmental, physiological and pathological processes;
gene regulation – the description of regulatory networks, based on the assumption that
genes regulated in parallel share common control mechanisms; diagnosis – identification
of patterns of gene expression that define disease states and that may represent prognostic
indicators and drug discovert and toxicology.
Gene expression techniques have also several limitations: the output from the analysis
of a microarray experiment is usually a large data spreadsheet filled with numbers related
to the signal intensity for each gene on the chip. Further analysis is required to identify
groups of genes that are similarly regulated across the biological samples under study. It is
not a quantitative method, and so it does not reflect perfectly the reality.
In our study we extracted gene expression data from the GEO database (Wheeler et al.,
2001) as it is described on the following section3.1.
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2.3 Protein-Protein Interactions
Proteins play crucial roles in living cells and in life; they perform their functions under
constant motions, adopting different shapes, flexibility and interactions with other biological
molecules. Typically, within cells, proteins interact with other proteins, metabolites and
nucleic acids. Protein-protein interactions occur when two or more proteins bind together,
often to carry out their biological function.
Proteins, as macromolecules they are, are composed of long complex chains of molecules
(polymers) made up of simpler, smaller subunits (monomers). They are joined together in
a process known as dehydration synthesis, in which a covalent bond is formed between two
monomers by releasing a water molecule. Proteins are ready to interact under physic laws
that are related with the superface and flexibility of the proteins.
Interactions between proteins are important for the majority of biological functions.
For example, signals from the exterior of a cell are mediated to the inside of that cell
by protein-protein interactions of the signalling molecules. Proteins might interact for a
long time to form part of a protein complex (group of two or more associated polypeptide
chains), a protein may be carrying another protein or a protein may interact briefly with
another protein just to modify it. In conclusion, protein-protein interactions are important
for virtually every process in a living cell. Information about these interactions improves
our understanding of diseases and can provide the basis for new therapeutic approaches.
Protein-protein interactions have been measured using a variety of assays, such as in-
munoprecipitations and the yeast two-hybrid approach. These techniques have been scaled
up to measure interactions on a genome-wide level. High-throughput techniques have also
been developed to systematically identify protein complexes using affinity purification tech-
niques followed by mass spectrometry to sequence proteins.
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One of the grand challenges for molecular biology is to reconstruct the complete network
of protein interactions within cells. This so-called interactome sheds unprecedented light
on the inner workings of cellular machinery. Analysis of the network should also permit
scientist to select protein targets for therapeutic intervention by understanding the under-
lying mechanisms of action. Eventually, protein networks may also be used to construct
comprehensive dynamic models of molecular interactions within cells, allowing scientist to
quantitatively predict the outcome of experiments.
High-throughput sequencing has facilitated the prediction of proteins coded within a
genome, thus providing a list of the interactome’s constituents, constructing such powerful
models on a genome-wide scale.
Along with experimental approaches to detect protein interactions, computational meth-
ods have also been developed. These methods search for pairs of proteins that have co-
evolved, implying that they are likely to be interacting within the cell. Although com-
putationally derived interactions are generally not as reliable as experimentally measured
ones, they provide a more complete and accurate understanding of protein interactions in
combination with experimental data.
In summary, proteins do not act alone, and they often form complexes with other proteins
to perform a specific task. The existing interactions between them have been studied and we
use this information in order to see how the interactome evolves depending on the expression
of the proteins.
As we presented in the section1.1, Johnsson and Bates (2006) show that known cancer
genes exhibit a network topology that is different from that of protein not documented as
being mutated in cancer. In particular, cancer proteins show an increase in the number of
proteins they interact with.
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In this study we used a collection of six protein interactions databases PINA (Wu et al.,
2009) : IntAct, MINT, BioGRID, DIP, HPRD and Mpact.
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Chapter 3
Biological Datasets
Gene expression data is available in public sources due to the availability of high-throughput
experimental data as well as protein interaction data.
3.1 Gene Expression Data
Gene Expression Omnibus (GEO)3 is a public functional genomics data repository offered
by the NCBI15 (National Centre for Biotechnology Information). They provide array- and
sequence-based data, as experiments and curated gene expression profiles.
There are thousands of gene expression samples available related with different types of
diseases. A sample describes the conditions under which an individual sample was handled,
the manipulations it underwent and the abundance measurement of each element derived
from it; e.g. for a gene expression DNA microarray it would provide a list of (already pre-
processed) expression values for each gene. Each sample record or identification is assigned
a unique and stable GEO accession number of type GSMxxx (Appendix A). To know which
samples choose, we used Barcode, the human transcriptome repository, so as to select the
samples related with gene expression experiments related with different tissues in normal
and tumoral conditions.
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The Gene Expression Barcode (Zilliox and Irizarry, 2012) is a public repository that
provides reliable absolute measures of expression for most annotated genes for 131 human
and 89 mouse tissue types, including diseased tissue. They also implement an algorithm that
leverages information from the GEO and ArrayExpress public repositories to build statistical
models that permit converting data from a single microarray into expressed/unexpressed
calls for each gene.
As their approach provides the original expression data for each tissue; in our study
we used gene expression experimental samples in normal and tumoral cases of the following
tissues: ovary, breast, colon, lung, liver and kidney. The identifications of the samples (GSM
id’s) are presented on Appendix A.
A platform defines the list of elements that may be detected and quantified in an exper-
iment; e.g. for a gene expression DNA microarray it would provide a list of the cDNA spots
or oligonucleotide probesets on one array, each time with an annotation of the gene. The
platform of the technology used in all these samples was HGU133Plus2 (Affymetrix Human
Genome U133 Plus 2.0 Array Annotation Data) [1]. This platform contains information
measures for 10750 genes.
For microarrays to be used in a clinical setting to aid in diagnosis or treatment, one needs
to be able to gain useful information from a single microarray hybridization: one needs to
be able to:
• Preprocess a single microarray.
• Estimate the expression of each gene on the array.
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A recent work by McCall et al. (2010) provide a method of single array preprocessing
called Frozen Robus Microarray Analysis (fRMA). Previous work by Zilliox and Irizarry
(2007) and, more recently, by McCall et al. (2009) show how to obtain gene expression
estimates from the preprocessed data. Specifically, Zilliox and Irizarry (2007) develop a
method to map gene intensities into a vector of ones and zeros denoting which genes are
expressed (ones) and unexpressed (zeros) in a given example. They call to this sequence of
ones and zeros a gene expression barcode.
In this study we implemented several scripts in order to follow the steps briefly shown
in fig.3.1, then we explain some important facts of each stage.
Figure 3.1: Analysis Stages of the Gene Expression Data
3.1.1 Preprocessing Single Affymetrix Microarrays
Before preprocess the raw data we extracted the list of samples (GSM files) that are shown
on the Appendix A, from the GEO repository. For that, we used the GEOquery package.
With the function, getGEO(’gsm-id’), we got all the CEL files corresponding to all the
studies. (Each GSM contains a CEL files).
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For Affymetrix microarray data it is customary to view CEL files as the starting point for
preprocessing and analysis. One or more CEL files can be read into R using the ReadAffy
function from the affy package to produce an AffyBatch object (Gautier et al., 2004). We
adopted this convention and referred to the probe-level intensities from a single CEL file
stored in an AffyBatch object as the raw data.
This is a fundamental step in order to do the fRMA analysis.
3.1.2 Frozen Robust Multiarray Analysis (fRMA)
The goal of fRMA is to obtain reliable gene-level intensities from a single microarray
hybridization. This amounts to converting raw probe-level intensities into background-
corrected, normalized gene-level intensities. The fRMA package contains a function fRMA
which takes an AffyBatch as input and produces an object containing gene-level expression
values.
To preprocessed single arrays using fRMA, one needs a number of frozen parameter
vectors. Among these are the reference distribution to which the data are normalized and
the probe-effect estimates. McCall et al. (2009) computed these frozen parameters for three
popular Affymetrix platforms, and one of them is the one used in this study: hgu133plus2
[1].
3.1.3 Gene expression barcode
The creation of a gene expression barcode is designed to convert gene-level intensities into
gene expression estimates. The algorithm by default takes the output from frma and creates
a gene expression barcode: we get a z-score for each gene and each sample.
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In conclusion, for every tissue and every sample we got 10740 genes with its corresponding
z-score, denoting the intensity of the expression of the gene. Z-score is a test of statistical
significance that helps decide whether or not to reject the null hypothesis. Z-scores are
measures of standard deviation. Calculating the distribution function of each z-score, with
the pnorm function, we also get the probability of the expression of each gene (values between
0 and 1) of being expressed.
The presenting approach, based on the philosophy of SA, uses as information of nodes
the probability of each gene of being expressed, if it does, and the probability of not being
expressed, if it does not.
3.2 Protein-protein Interaction Data
For the protein-protein interaction we used data from PINA (Wu et al., 2009). This database
includes a quaterly updated, nonredundant data based on integration of data from six public
PPI databases: IntAct, MINT, BioGRID, DIP, HPRD and MIPS Mpact.
These databases provide us protein-protein interactions data using different kind of
methodology: IntAct provides all interactions derived from literature curation or direct
user submissions. MINT stores information about molecular interactions by extracting ex-
perimental details from work published in peer-reviewed journals. BioGRID is a curated
protein-protein and genetic interactions database from primary literature and compiled by
in house large-scale curation efforts. DIP catalogs experimentally determined interactions
between proteins, combining information from a variety of sources. HPRD contains manu-
ally curated scientific information pertaining to the biology of most human proteins. And
MIPS offers a collection of manually curated high-quality protein-protein interaction data
collected from the scientific literature by expert curators.
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3.2.1 PPI data extraction
Once we extracted the information about the protein interactions we made an enrichment
analysis on protein aliases. Each protein might have more than one identification. So as to
consider all the combinations, we made the expansion on the network’s aliases.
For all the existing genes on the platform used for the gene expression analysis there is
its corresponding gene or alias on the protein network.
The resulting network has 64001 protein-protein interactions.
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Chapter 4
Pseudo Deterministic Simulated
Annealing Approach
Our aim is to see different dynamic structures on the protein-protein interactions network,
mapping into the network expression of the genes in normal and tumoral tissues. Following
the idea of Johnsson and Bates (2006), our hypothesis is that there is more destabilization
on the network related with tumoral data, there are more interactions between proteins and
a mutation or change in any of them causes a major destabilization on the network because
it is more connected.
The novel method we are presenting in this study is the approach based on the main idea
of Simulated Annealing (SA) method. SA technique permits to map interactions between
every node, represent each node, as well as calculate the energy of the overall network. There
is nothing done yet in this field to calculate and weight a network based on its “energy”.
This is our contribution in this work.
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4.1 General Comments
SA is a probabilistic method proposed by Kirkpatrick et al. (1983) and Cerny (1985) in
combinatorial optimization for finding the global minimum of a cost function that may
possess several local minima. It works by emulating the physical process whereby a solid is
slowly cooled so that when eventually its structure is “frozen”, this happens at a minimum
energy configuration.
This technique was first described by Metropolis et al. (1953) in the thermodynamic
field. The main idea based on traditional processing of metals, a standard method to improve
the quality of the metal is to heat it up to high temperatures, then slowly cool it down.
Sometimes this is done in repetitive cycles. This method is called annealing.
The idea is to introduce a variable E (which may not have anything at all to do with
any thermodynamic energy nor linked with a temperature). Then a generalized Metropolis
scheme is used to simulate the system at the energy E under a given temperature, while E
is gradually cooled down from some high starting temperature.
This technique has been demonstrated to be a successful approach in order to solve a
variety of optimization problems (Laarhoven and Aarts, 1988). Duda et al. (2001) proposed
a modified version of the original SA approach called deterministic against the stochastic
version, which is essentially computationally slow, in part because of the discrete nature of
the search along the space of all configurations.
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4.2 Energy Minimization based on SA
In this study we propose a new approach based on the idea of simulated annealing as we
mentioned previously. In the Appendix B is included the whole description of the determin-
istic SA (DSA) according to Haykin (1994) and Duda et al. (2001) which also follows the
physical analogy. It is based on a set of nodes interconnected among them and each one with
its associated state. These states evolve toward stable states based on the forces exerted
by the nodes interconnected and also through the temperature according to the scheduled
cooling process. Some nodes have influence over other nodes across these interactions and
also the weights defined in these relationships.
This structure can be seen as a network of nodes with their states being dynamically
updated toward a global stable state for the network. The network stability is measured by
an energy function, which is conveniently defined according to the nature of the problem
to solve. Again, this energy is inspired on the physical simulated annealing process, where
the metal achieves more stable states as it cools, i.e. achieves minimum energy. Minimum
energy values represent network stability. The term deterministic is because it is possible
to determine deterministically the evolution of the states as the temperature decreases.
The energy function involves both: 1) all states of the nodes and 2) the strength of the
interconnections. The algorithm reaches the convergence criterion when this energy achieves
its minimum value or a constant value, which indicates no more changes updating the states
occur.
Our proposed strategy is inspired on the definition of an energy function, where as in the
general deterministic approach it measures the stability of the network, where less energy
is related to more stability. We cannot say that we are applying the DSA method to its
fullest extent. This justifies the name of the proposed approach as PseudoDSA (hereinafter
PDSA). In our case, the fact of using an energy function that decreases along interactions
or time does not make sense due to the characteristics of the biological problem described,
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which is to be solved. For this reason, as we ignore the descent of the energy during the
time we cannot talk about a direct and a proper application of a DSA method, but based to
that. This fact justifies the previous statements we already described about the inspiration
of our approach on SA, not making use of all the methodology. Basically we are inspired
on the idea and we implemented a new approach using the philosophy extracted from DSA
methodology.
Figure 4.1: Representation of states for the PseudoDSA approach
Our system is represented by a protein-protein interaction network. Nodes represent
proteins. As described in Fig.4.1, each Si represents the probability of being expressed the
protein i, if it is expressed; as well as the probability of not being expressed if it is not
expressed. Specifically all Si represent the states of the nodes in the original DSA approach.
Edges show existing interactions between proteins if they both are expressed. Each Wij
represents the weight described in equation (1), we have defined this parameter in order to
define the PDSA method.
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As mentioned before, we based mainly on the idea of using an energy function that
minimizes the energy in the system as the network reaches more stable states. The weights
(Wij) of the connections or interactions are defined in equation 1.
Wij =

−1 if Si expressed, Sj expressed
−1 if Si expressed, Sj not expressed, prob(Si) > prob(Sj) (1)
+1 if Si expressed, Sj not expressed, prob(Si) < prob(Sj)
+1 if Si not expressed, Sj not expressed
Following the main idea of the SA algorithm, the energy function E is defined as the
sum of the energy from all the influenced nodes. These influences are calculated multiplying
the value of each node (Si) by the associated weights with all nodes interconnected with the
first one (Wij). Equation (2) summarizes this computation:
E = −
∑
i
∑
j
WijSiSj (2)
An interaction between two proteins happens when both of them are expressed. In our
case, the energy decreases for those node connections that involve an interaction between
proteins that are both expressed. Indeed, under such situation the three terms involved in
equation (2) achieves their maximum values and the product also, because of the negative
sign in equation (2) the energy decreases, i.e. this represents a favorable situation. Favorable
situations also occur when the probability (Si,Sj) of the protein expressed (to be expressed)
is higher than the probability of the other one of not being expressed.
23
Similarly, the energy achieves minimum values when the products WijSiSj are maxima,
according to the definition of equation (2) this always occurs when those nodes connections
involving an interaction between proteins that are not expressed or when the probability of
the protein unexpressed for not being expressed is higher than the probability of the other
one of being expressed.
Briefly, as mentioned before an overall low energy value will be related with a more
stability of the network. It means that there are not so many interactions between proteins
that are both expressed or at least the number of interaction between unexpressed genes is
higher than the expressed ones. The more expressed protein interactions the network have,
more will affect to the stability of the network if a mutation or change exists.
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Chapter 5
Results
In this chapter we present different results obtained with the proposed PDSA approach,
described on section 4.2. As mentioned before this study is based on the values provided by
the energy function defined in equation (2), which simulates the network stability.
For each tissue, we studied the stability of the protein interaction network in tumoral and
normal samples. As we have described on chapter 4, we implemented an original method-
ology based on the evolution of the well-known simulated annealing approach customized
for study the energy and simulate the stability of a protein network. Fig.5.1 describes the
steps we did during the different tests carried out during our experiments.
We simulated in two different ways the stability of the protein network: 1) mapping all
the genes from the gene expression analysis stage (around 10750 genes) and 2) mapping
only the overexpressed genes.
When we studied the overall expression we got significant results for all the tissues but
not for breast. We realized that there were a large amount of genes in tumoral and normal
cases in breast with a similar gene level expression. Including all of them in the study could
be considered adding noise.
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Figure 5.1: Main schema of the overall study mapping all the genes
This is the reason why we simulated the network with those genes overexpressed in
tumoral but not in normal and viceversa, in order to get even more significant results in the
simulation, not just for the breast tissue; we also did for the rest of tissues.
We used the algorithm for the tumor and normal pairs available for various tissues. For
each interaction, we mapped into the protein-protein interaction network the gene expression
analysis values and obtained the corresponding energy value, E, from the simulated network.
In other words, we simulated an interaction network for every sample and studied the energy,
E, of the corresponding network. The global energy in one normal tissue is the sum of all
the energy values resulting after the simulations of all the normal samples; as well as the
global energy in one tumor tissue is the sum of all the energy values resulting after the
simulations of all the tumor samples in that tissue.
Boxplots represented by figures from Fig.5.3 to Fig.5.7 describe the distribution of the
energy of the network simulated, in other words, the stability of the network (as described
in the section 4.2), in normal tissues represented in blue and tumoral tissues, in red.
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Figure 5.2: Main schema of the overall study mapping genes overexpressed
On one hand, the left subsection of each figure shows the resulting energy value of
the simulated network in normal and tumor tissues, considering the information of all the
genes. On the other hand, the subsection on the right represents the resulting energy value
of the simulated network in normal and tumor tissues taking into account only those genes
overexpressed in normal but not in tumor and those overexpressed in tumor and not in
normal.
Figure 5.3: Energy distribution mapping every genes and overexpressed genes in ovary
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For the ovary cancer data set we observe a clearly different distribution of normal and
tumor tissues.
When the expression of all genes is considered, the median of the energy for the normal
samples is of 0.7 while in the tumors is more than 1.0. This difference is more significant
when only genes that are overexpressed are considered with a median for the normal samples
is 0.2 and of 0.9 for the tumor samples.
The Mann-Whitney test evaluates whether the medians on a test variable differ signif-
icantly between two groups. We calculated a Mann-Whitney test in order to prove that
these two energy distributions (in normal and tumor tissues) are significantly different: we
get a p-value of 4.97e-07 when we compare the energy distributions in normal and tumor
samples taking into account all the genes and a p-value of 2.8e-09 comparing both energy
distributions, mapping only genes overexpressed.
The same tendency can be observed in the colon cancer data set. In this case we register
a lower network energy when we map the expression of the genes in normal tissues. In this
case the difference between normal and tumor tissues is even more significant. Mapping
only overexpressed genes makes the differences tumor/normal even larger.
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Figure 5.4: Energy distribution mapping every genes and overexpressed genes in colon
In summary, the energy distribution in both cases, normal and tumor, are significantly
different. Not only the median is different between them, even the third quartile in the
normal samples do not reach the first quartile in the tumoral samples; meaning that the
energy distribution considering gene expression on normal tissues is more directed to lower
energy values. We demonstrate this calculating a Mann-Whitney test in both energy distri-
butions: a p-value of 2.33e-06 considering all the genes and a p-value of 5.11e-06 considering
overexpressed genes, prove that both distributions are significantly different.
Fig.5.5 shows the energy distribution of the network on normal and tumoral cases in
the kidney dataset. We can extract almost the same conclusions as we did with ovary and
colon tissues. The energy distribution is different, even more considering overexpressed
genes. Mapping all the genes on the network, we can observe that the median is different
in normal and tumoral samples; but the third quartile in normal overlaps with the first
quartile in tumoral samples. Calculating the Mann-Whitney test we obtain a p-value of
7.03e-05 taking into account all the genes and a p-value of 2.67e-15 mapping only genes
overexpressed.
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Figure 5.5: Energy distribution mapping every genes and overexpressed genes in kidney
The energy distribution between tumor and normal samples in the liver dataset, is sig-
nificantly different as we can observe in Fig.5.6. Mapping all the genes as well as only the
overexpressed genes show a total different configuration of the energy distribution. Calcu-
lating the Mann-Whitney test returns p-values of 1.9e-7 and 2.44e-14 respectivelly.
Figure 5.6: Energy distribution mapping every genes and overexpressed genes in liver
Fig.5.7 describes the last study. We cannot see any significant difference between normal
and tumoral distributions, when we map all genes into the network. The Mann-Whitney
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test calculates a p-value of 0.45, that means that both distributions are not significantly
different. But we do taking into account only genes that are overexpressed in tumor but
not in normal, and viceversa. The median is significantly different, as well as the entire
distribution and the p-value provided by the Mann-Whitney test is around 3.81e-07.
Figure 5.7: Energy distribution mapping every genes and overexpressed genes in breast
This different behaviour in the breast cancer dataset comparing to the previous ones can
be due to the noise when we take into account the level of expression of all the genes. This
might be due to a large amount of genes that have a similar gene expression level in tumor
and normal breast samples. And so, when we only take into account those genes that are
overexpressed in tumor and not normal samples and viceversa, we can observe a significant
differences between both simulated networks’ energy distribution.
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Chapter 6
Conclusions and future work
6.1 Conclusions
Our main idea was to prove that proteins related with cancer exhibit a different network
dynamic structure than proteins not related with cancer. We used gene expression data in
order to see how the expression of each gene and its interactions along the network have
influence on the total interactions system.
The main contribution of this work consists in the design of an approach based on
the simulated annealing theory, representing the protein interaction network as a system
of nodes with their states being dynamically updated toward a global stable state for the
network. Our proposed strategy is inspired on the definition of an energy function, whereas
in the general deterministic approach measures the stability of the network: less energy is
related to more stability.
The network stability in tumor and normal samples in ovary, breast, colon, kidney and
liver experimental data sets is significantly different. The distribution of the energy of the
simulated network in the samples is significantly different, emphasizing lower energy values
and so more stability in normal tissues than in cancer related samples.
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A reason that could explain this behaviour would be the chaos that any tumor causes: the
lack of control on the cell growth. Cancer is fundamentally a disease of failure of regulation
of tissue growth. In order for a normal cell to transform into a cancer cell, the genes which
regulate cell growth and differentiation must be altered. So, tumor samples represent a
major destabilization because of an increased number of proteins that are expressed and are
interacting with others that are also expressed.
For every tissue we have studied, except breast, we have seen a significantly different
energy distribution in normal and tumor samples, taking into account the level of expression
of all the genes. Along the same line, when we map the level of expression of genes that
are overexpressed we have seen in every tissue even a more significant difference between
tumor and normal energy distributions. An interpretation of this could be that lots of genes
have a similar expression profile in normal and tumor samples, but those genes that are
differentially overexpressed between normal and tumor are the responsible to represent a
different dynamic structure of the protein interaction network.
An interpretation of this could be that a large amount of genes have a similar expression
profile in normal and tumor samples, but those genes that are differentially overexpressed
between normal and not tumor and viceversa, are the responsible to represent a different
dynamic structure of the protein interaction network.
We propose this new methodology to simulate a dynamical protein structure and so
study the stability of the protein interaction network based on gene expression.
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6.2 Future Work
Based on the results obtained we propose the following considerations in order to continue
this lines of the research.
We have seen that the energy between normal and tumor data samples is different after
simulating a dynamical structure of the protein interaction network for each sample. But
we do not know what happens in the network, whether this result is derived of an increase
number of hubs (proteins with many interaction partners). Maslov et al. (2011) show that if
a given number of proteins and distributed interactions among them are taken randomly, it
is hardly find any particular protein that would have a lot of interactions. Proteins would all
“talk” randomly with each other in such a network. So, hubs of highly-interacting proteins
are not something that would be expect to happen by pure chance.
In this work we have considered as statics the relations between proteins. Another inter-
esting idea is to implement a methodology that considers also the influence of the protein
interactions. Vandin et al. (2012) propose something similar in order to find subnetworks of
genes in an gene interaction network where the mutational status of these genes in the sub-
network are significantly associated with a phenotype. For that, they design an algorithm,
HotNet, that finds groups of mutated genes using a heat diffusion model and two-stage sta-
tistical test. The idea would be to design a heat diffusion model so as to calculate the overall
interactions between genes, instead of considering only the direct connections between them.
A straightaway idea in which we are currently working on is to apply also copy number
variation (CNV) data in our PDSA approach. Chromosomal DNA copy number is the
number of copies of genomic DNA. Normal somatic cells have two copies of the autosomal
chromosomes; the copy number is two. In addition, cells of normal males have one copy of
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the X and of the Y chromosome. Nuclei of Down syndrome patients show an extra copy of
chromosome 21, whereas in cancer tissue the copy number may vary considerably over the
genome. Chromosomal aberrations are a key event in the developmental and progression of
cancer (Lengauer et al. 1998). And array comparative genomic hybridization (aCGH) is a
high resolution method to detect these DNA copy numbers (Pinkel and Albertson, 2005).
Analyze this kind of data and remodelate our PDSA methodology is our most immediate
proposal. We are going to study how protein interaction network’s energy changes based on
the gene expression data and the number of copies of each gene.
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Appendix A
Appendix A - Gene Expression Samples
The following samples have been used in the study:
• Ovary
– Normal samples: GSM80757, GSM80758, GSM80759, GSM80780, GSM175789,
GSM176131, GSM176136, GSM176237, GSM176318.
– Tumoral samples: GSM38064, GSM38065, GSM38066, GSM38070, GSM38071,
GSM38088, GSM38095, GSM46815, GSM46821, GSM46830, GSM46831, GSM46839,
GSM46853, GSM46886, GSM46897, GSM46898, GSM46910, GSM46911, GSM46918,
GSM46925, GSM249675, GSM249676, GSM249677, GSM249678, GSM249714,
GSM249715, GSM249716, GSM249717, GSM249718, GSM249719, GSM249720,
GSM249721, GSM249722, GSM249723, GSM249724, GSM249725, GSM249726,
GSM249727, GSM249728, GSM249729, GSM249730, GSM249731, GSM249732,
GSM249733, GSM249734, GSM249735, GSM249736, GSM249737, GSM249738,
GSM249739, GSM249740, GSM249741, GSM249742, GSM249743, GSM249744,
GSM249745, GSM249746, GSM249747, GSM249749, GSM249750, GSM249751,
GSM249752, GSM249753, GSM249754, GSM249755, GSM249756, GSM249757,
GSM249758, GSM249759, GSM249760, GSM249762, GSM249763, GSM249766,
GSM249767, GSM249769, GSM249770, GSM249773, GSM249774, GSM249775,
GSM249776, GSM249777, GSM249778, GSM249779, GSM249780, GSM249781,
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GSM249782, GSM249783, GSM249784, GSM249785, GSM249786, GSM249788,
GSM249789, GSM249790, GSM249791, GSM249792, GSM249793, GSM249794,
GSM249795, GSM249796, GSM249797, GSM249798, GSM249799, GSM249801,
GSM249802, GSM249803, GSM249804, GSM249805, GSM249807, GSM249808,
GSM249809, GSM249811, GSM249812, GSM249815, GSM249816, GSM249817,
GSM249818, GSM249819, GSM249820, GSM249821, GSM249822, GSM249824,
GSM249825, GSM249826, GSM249827, GSM249830, GSM249832, GSM249833,
GSM249835, GSM249836, GSM249837, GSM249838, GSM249839, GSM249840,
GSM249841, GSM249842, GSM249844, GSM249845, GSM249846, GSM249847,
GSM249848, GSM249849, GSM249850, GSM249851, GSM249852, GSM249853,
GSM249854, GSM249855, GSM249856, GSM249857, GSM249858, GSM249859,
GSM249860, GSM249861, GSM249862, GSM249863, GSM249866, GSM249868,
GSM249869, GSM249870, GSM249871, GSM249872, GSM249874, GSM249875,
GSM249876, GSM249877, GSM249878, GSM249879, GSM249880, GSM249881,
GSM249882, GSM249883, GSM249884, GSM249885, GSM249886, GSM249888,
GSM249889, GSM249890, GSM249892, GSM249893, GSM249894, GSM249895,
GSM249897, GSM249898, GSM249899, GSM249900, GSM249901, GSM249902,
GSM249903, GSM249904, GSM249905, GSM249906, GSM249907, GSM249908,
GSM249909, GSM249910, GSM249912, GSM249913, GSM249915, GSM249916,
GSM249917, GSM249918, GSM249919, GSM249920, GSM249922, GSM249923,
GSM249924, GSM249925, GSM249926, GSM249927, GSM249928, GSM249929,
GSM249930, GSM249932, GSM249933, GSM249934, GSM249936, GSM249939,
GSM249940, GSM249941, GSM249942, GSM249943, GSM249946, GSM249948,
GSM249950, GSM249951, GSM249953, GSM249954, GSM249955, GSM249956,
GSM249957, GSM249958, GSM249959, GSM249960, GSM249961, GSM249962,
GSM249963, GSM249965, GSM249966, GSM249967, GSM249968, GSM249969,
GSM249971, GSM249972, GSM249973, GSM249974, GSM249975, GSM249976,
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GSM249977, GSM249978, GSM249980, GSM249981, GSM249983, GSM249984,
GSM249985, GSM249986, GSM249987, GSM249988, GSM249990, GSM249992,
GSM249993, GSM249994, GSM249995, GSM249996, GSM249998, GSM249999,
GSM250000, GSM250001.
• Breast
– Normal samples: GSM85513, GSM85514, GSM85515, GSM85516, GSM85517,
GSM85518, GSM85519, GSM175792, GSM175795.
– Tumoral samples: GSM278156, GSM278157, GSM278158, GSM278159, GSM278160,
GSM278161, GSM278162, GSM278163, GSM278164, GSM278165, GSM278166,
GSM278167, GSM278168, GSM278169, GSM278170, GSM278171, GSM278172,
GSM278173, GSM278174, GSM278175, GSM278176, GSM278177, GSM278178,
GSM278179, GSM278180, GSM278181, GSM278182, GSM278183, GSM278184,
GSM278185, GSM38051, GSM38054, GSM38057, GSM38059, GSM38062, GSM38063,
GSM38080, GSM38081, GSM38082, GSM38083, GSM38086, GSM38090, GSM38091,
GSM38092, GSM38094, GSM38099, GSM38102, GSM38106, GSM38109, GSM38110,
GSM46816, GSM46820, GSM46827, GSM46836, GSM46846, GSM46849, GSM46852,
GSM46855, GSM46859, GSM46862, GSM46863, GSM46869, GSM46870, GSM46871,
GSM46873, GSM46874, GSM46880, GSM46883, GSM46885, GSM46890, GSM46891,
GSM46893, GSM46894, GSM46900, GSM46905, GSM46908, GSM89102, GSM85473,
GSM85474, GSM85475, GSM85476, GSM85477, GSM85478, GSM85479, GSM85480,
GSM85481, GSM85482, GSM85483, GSM85484, GSM85485, GSM85486, GSM85487,
GSM85488, GSM85489, GSM85490, GSM85491, GSM85492, GSM85493, GSM85494,
GSM85495, GSM85496, GSM85497, GSM85498, GSM85499, GSM85500, GSM85501,
GSM85502, GSM85503, GSM85504, GSM85505, GSM85506, GSM85507, GSM85508,
GSM85509, GSM85510, GSM85511, GSM85512, GSM124994, GSM124995, GSM124996,
GSM124997, GSM124998, GSM124999, GSM125000, GSM125001, GSM125002,
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GSM125003, GSM125004, GSM125005, GSM125006, GSM125007, GSM125008,
GSM125009, GSM125010, GSM125011, GSM125012, GSM125013, GSM125014,
GSM125015, GSM125016, GSM125017, GSM125018, GSM125019, GSM125020,
GSM125021, GSM125022, GSM125023, GSM125024, GSM125025, GSM125026,
GSM125027, GSM125028, GSM125029, GSM125030, GSM125031, GSM125032,
GSM125033, GSM125034, GSM125035, GSM125036, GSM125037, GSM125038,
GSM125039, GSM125040, GSM125041, GSM125042, GSM125043, GSM125044,
GSM125045, GSM125046, GSM125047, GSM125048, GSM125049, GSM125050,
GSM125051, GSM125052, GSM125053, GSM125054, GSM125055, GSM125056,
GSM125057, GSM125058, GSM125059, GSM125060, GSM125061, GSM125062,
GSM125063, GSM125064, GSM125065, GSM125066, GSM125067, GSM125068,
GSM125069, GSM125070, GSM125071, GSM125072, GSM125073, GSM125074,
GSM125075, GSM125076, GSM125077, GSM125078, GSM125079, GSM125080,
GSM125081, GSM125082, GSM125083, GSM125084, GSM125085, GSM125086,
GSM125087, GSM125088, GSM125089, GSM125090, GSM125091, GSM125092,
GSM125093, GSM125094, GSM125095, GSM125096, GSM125097, GSM125098,
GSM125099, GSM125100, GSM125101, GSM125102, GSM125103, GSM125104,
GSM125105, GSM125106, GSM125107, GSM125108, GSM125109, GSM125110,
GSM125111, GSM125112, GSM125113, GSM125114, GSM125115, GSM125116,
GSM125117, GSM125118, GSM125121, GSM125122, GSM151259, GSM151260,
GSM151261, GSM151262, GSM151263, GSM151264, GSM151265, GSM151266,
GSM151267, GSM151268, GSM151269, GSM151270, GSM151271, GSM151272,
GSM151273, GSM151274, GSM151275, GSM151276, GSM151277, GSM151278,
GSM151279, GSM151280, GSM151281, GSM151282, GSM151283, GSM151284,
GSM151285, GSM151286, GSM151287, GSM151288, GSM151289, GSM151290,
GSM151291, GSM151292, GSM151293, GSM151294, GSM151295, GSM151296,
GSM151297, GSM151298, GSM151299, GSM151300, GSM151301, GSM151302,
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GSM151303, GSM151304, GSM151305, GSM151306, GSM151307, GSM151308,
GSM151309, GSM151310, GSM151311, GSM151312, GSM151313, GSM151314,
GSM151315, GSM151316, GSM151317, GSM151318, GSM151319, GSM151320,
GSM151321, GSM151322, GSM151323, GSM151324, GSM151325, GSM151326,
GSM151327, GSM151328, GSM151329, GSM151330, GSM151331, GSM151332,
GSM151333, GSM151334, GSM151335, GSM151336, GSM151337, GSM151338,
GSM151339, GSM151340, GSM151341, GSM151342, GSM151343, GSM151344,
GSM151345, GSM232194, GSM232195, GSM232196, GSM232197, GSM232198,
GSM232199, GSM232200, GSM232201, GSM232202, GSM232203, GSM232204,
GSM232205, GSM232206, GSM232207, GSM232208, GSM232209, GSM232210,
GSM232211, GSM232212, GSM232213, GSM232214, GSM232215, GSM232216,
GSM232217, GSM232218, GSM232219, GSM232220, GSM232221, GSM232222,
GSM232223, GSM232224, GSM232225, GSM232226, GSM232227, GSM232228,
GSM232229, GSM232230, GSM232231, GSM232232, GSM232233, GSM232234,
GSM232235, GSM232236, GSM232237, GSM232238, GSM232239, GSM232240,
GSM232241, GSM232242, GSM232243, GSM232244, GSM232245, GSM232246,
GSM232247, GSM232248, GSM232249, GSM232250, GSM232251, GSM232252,
GSM232253, GSM232254, GSM232255, GSM232256, GSM232257, GSM232258,
GSM232259, GSM232260, GSM232261, GSM232262, GSM232263, GSM232264,
GSM232265, GSM232266, GSM232267, GSM232268, GSM232269, GSM232270.
• Colon
– Normal samples: GSM95473, GSM95474, GSM95475, GSM95476, GSM95477,
GSM95478, GSM95479, GSM95480, GSM175905.
– Tumoral samples: GSM38055, GSM38061, GSM38074, GSM38075, GSM38089,
GSM38105, GSM38107, GSM46823, GSM46832, GSM46841, GSM46845, GSM46857,
GSM46861, GSM46864, GSM46865, GSM46877, GSM46878, GSM46887, GSM46895,
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GSM46899, GSM46915, GSM46921, GSM46924, GSM89103.
• Liver
– Normal samples: GSM279063, GSM279064, GSM279065, GSM80728, GSM80729,
GSM80730, GSM80739, GSM138595, GSM138596, GSM155919, GSM155926,
GSM155927, GSM155928, GSM155947, GSM155948, GSM155961, GSM155964,
GSM155988, GSM155989, GSM176332, GSM176333, GSM176334, GSM176335.
– Tumoral samples: GSM38078, GSM38108, GSM46848, GSM139131, GSM143545,
GSM143546, GSM143547, GSM143548, GSM143549, GSM143550, GSM143551,
GSM143552, GSM143553, GSM248688, GSM248689, GSM248690, GSM248691,
GSM248692, GSM248693, GSM248694, GSM248695, GSM248696, GSM248697,
GSM248698, GSM248699, GSM248700, GSM248701, GSM248702, GSM248703,
GSM248704, GSM248705, GSM248706, GSM248707, GSM248708, GSM248709,
GSM248710, GSM248711, GSM248712, GSM248713, GSM248714, GSM248715,
GSM248716, GSM248717, GSM248718, GSM248719, GSM248720, GSM248721,
GSM248722, GSM248723, GSM248724, GSM248725, GSM248726, GSM248727,
GSM248728, GSM248729, GSM248730, GSM248731, GSM248732, GSM248733,
GSM248734, GSM248735, GSM248736, GSM248737, GSM248738, GSM248739,
GSM248740, GSM248741, GSM248742, GSM248743, GSM248744, GSM248745,
GSM248746, GSM248747, GSM248748, GSM248749, GSM248750, GSM248751,
GSM248752, GSM248753, GSM248754, GSM248755, GSM248756, GSM248757,
GSM248758, GSM248759, GSM248760, GSM248761, GSM248762, GSM248763,
GSM248764, GSM248765, GSM248766, GSM248767, GSM248768, GSM248769,
GSM248770, GSM248771, GSM248772, GSM248773, GSM248774, GSM248775,
GSM248776, GSM248777, GSM248778.
• Kidney
– Normal samples: GSM279060, GSM279061, GSM279062, GSM281311, GSM281312,
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GSM281314, GSM281315, GSM281316, GSM175911, GSM198783, GSM198785,
GSM240832, GSM240833, GSM240834, GSM240835, GSM240836, GSM240837,
GSM240838, GSM240839, GSM240840, GSM240841, GSM240842, GSM240843,
GSM240844, GSM240947, GSM240948.
– Tumoral samples: GSM281278, GSM281279, GSM281280, GSM281281, GSM281282,
GSM281283, GSM281284, GSM281285, GSM281286, GSM281287, GSM281288,
GSM281289, GSM281290, GSM281291, GSM281292, GSM281293, GSM281294,
GSM281295, GSM281296, GSM281297, GSM281298, GSM281299, GSM281300,
GSM281301, GSM281302, GSM281303, GSM281304, GSM281305, GSM281306,
GSM281307, GSM281308, GSM281309, GSM281310, GSM281313, GSM281317,
GSM281318, GSM281319, GSM281320, GSM281321, GSM281322, GSM281323,
GSM281324, GSM281325, GSM281326, GSM281327, GSM281328, GSM281329,
GSM281330, GSM281331, GSM281332, GSM281333, GSM281334, GSM281335,
GSM281336, GSM281337, GSM281338, GSM281339, GSM281340, GSM281341,
GSM281342, GSM281343, GSM281344, GSM305099, GSM305100, GSM305101,
GSM305102, GSM305103, GSM305104, GSM305105, GSM305106, GSM305107,
GSM305108, GSM305109, GSM305110, GSM305111, GSM305112, GSM305113,
GSM305114, GSM305115, GSM305116, GSM38073, GSM46825, GSM46826, GSM46847,
GSM46858, GSM46875, GSM46881, GSM46882, GSM46892, GSM89104.
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Appendix B
Pseudocode for the Deterministic
Simulated Annealing Method
Description of the deterministic simulated annealing:
begin
initialize E,Wij, Si, Sj, i, j = 1..N
t = 0
while t <= tmax
E = −
N∑
i
N∑
j
WijSiSj
t = t+ 1
end
end
whereas:
E is the system’s final energy. t corresponds to a gene expression sample in each tissue
and type (normal or tumor). Wij describes the weight explained in Equation 1, representing
the existing influence between nodes Si and Sj. In our approach Si is the probability of
each gene of being expressed.
47
